Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Inotiv ( (NOTV) ).
On March 23, 2026, Inotiv, Inc. disclosed that its lenders granted a waiver of the minimum liquidity covenant under its existing Credit Agreement for the liquidity test dates of March 20 and March 27, 2026. The limited waiver, which did not alter any other provisions of the Credit Agreement, temporarily eases compliance pressure on Inotiv’s near-term liquidity requirements and provides short-term flexibility under its financing arrangements.
By securing this waiver, Inotiv avoids an immediate potential covenant breach linked to its liquidity levels for those specific dates, which could have triggered default remedies from lenders. While the agreement’s broader terms remain intact, the move signals active engagement between the company and its creditors around financial covenant management and may be closely watched by investors and other stakeholders monitoring Inotiv’s balance-sheet resilience.
The most recent analyst rating on (NOTV) stock is a Hold with a $0.29 price target. To see the full list of analyst forecasts on Inotiv stock, see the NOTV Stock Forecast page.
Spark’s Take on NOTV Stock
According to Spark, TipRanks’ AI Analyst, NOTV is a Neutral.
The score is held down primarily by weak financial quality (ongoing losses, negative cash flow, and high leverage) and the related liquidity/refinancing pressure highlighted on the earnings call. Technicals show only early, short-term improvement within a broader downtrend, while valuation provides limited support due to negative earnings and no dividend. Operational momentum in DSA is a notable positive, but listing-compliance risk and RMS volume weakness add meaningful uncertainty.
To see Spark’s full report on NOTV stock, click here.
More about Inotiv
Inotiv, Inc. is a contract research organization operating in the life sciences sector, providing nonclinical and analytical drug discovery and development services to pharmaceutical, biotech, and related industries. The company focuses on supporting clients’ research pipelines through outsourced laboratory services and specialized scientific expertise.
Average Trading Volume: 505,734
Technical Sentiment Signal: Sell
Current Market Cap: $11.24M
For a thorough assessment of NOTV stock, go to TipRanks’ Stock Analysis page.